Pharmaceutical sales-a method of disease surveillance?

Journal of Environmental Health

Volumn 60, Issue 4, 1997, Pages 8-14

  Rodman, Jane Somsel ^a   Frost, Floyd ^a   Davis Burchat, Lili ^a   Fraser, David ^a   Langer, Jeff ^a   Jakubowski, Walter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT;

ANTIDIARRHEAL MEDICATION; CRYPTOSPORIDIOSIS; DISEASE PATTERN; PHARMACEUTICAL SALES;

ARTICLE; CRYPTOSPORIDIOSIS; DRUG MARKETING; DRUG MONITORING; EPIDEMIC; HUMAN; UNITED STATES;

USA, NEW MEXICO; USA, WISCONSIN, MILWAUKEE;

EID: 0030809942     PISSN: 00220892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Frost, F.J., R.L. Calderon, and G.F. Craun (1996), "Waterborne Disease Surveillance," Journal of the American Water Works Association, September:66-78.
2. Berkelman, R.L., R.T. Bryan, J.M. Hughes, J.W. LeDuc, and M.T. Osterholm (1994), "Infectious Disease Surveillance: A Crumbling Foundation," Science, 264(5157):368-370.
3. Frost, F.J., R.L. Calderon, and G.F. Craun (1995), "Waterborne Disease Surveillance: Findings of a Survey of State and Territorial Epidemiology Programs," Journal of Environmental Health, 58:6-11.
4. Foster, L.R. (1990), "Surveillance for Waterborne Illness and Disease Reporting: State and Local Responsibilities," Methods for the Investigation and Prevention of Waterborne Disease Outbreaks, G.F. Craun, ed., EPA/600/1-90/005a, Washington, D.C.: U.S. EPA, pp. 39-43.
5. Craun, G.F. (Oct. 7, 1994), Report of the New York City's Advisory Panel on Waterborne Disease Assessment, New York: New York City Department of Environmental Protection.
6. Las Vegas Cryptosporidiosis Review Panel (1995), Report to the California-Nevada Section of the American Water Works Association, Southern Nevada Water Authority, Las Vegas Valley Water District, and AWWA Research Foundation, Denver, Co: AWWA.
7. Collin, J.F., J.M. Foliguet, J.J. Melet, and M. Morlot (1981), "Eau d'Adduction Publique et Gastro-Enterites en Meurthe-et-Moselle," Journal Francais d'Hyadrobologie, 35:155-174.
8. Maggini, M., S. Alegiani, B. Caffari, R. Raschetti, and S. Salmaso (1991), "Epidemiological Use of Drug Prescriptions as Markers of Disease Frequency: An Italian Experience," Journal of Clinical Epidemiology, 44:1299-1307.
9. Mykol, Y., A. Ashendorff, M. Layton, J. Miller, and A. Seeley (1996), "Anti-Diarrheal Medicine Sales and Clinical Laboratories Surveillance for Gastrointestinal Illnesses Outbreak Detection," Proceedings of the Annual Meeting of the American Public Health Association, p. 242.
10. Taylor, Jean (May 8, 1997), Maryland State Department of Health, Baltimore, Maryland, personal communication.
11. Blair, Kathy (May 29, 1996), City of Milwaukee Department of Health, Milwaukee, Wisconsin, personal communication.
12. Goldstein, S.T., A.J. Bryant, S.D. Griffiths, B.L. Herwaldt, A.W. Hightower, D.D. Juranek, D.G. Martin, J.L. Mesnik, O. Ravenholt, and R.R. Reich (1996), "Cryptosporidiosis: An Outbreak Associated with Drinking Water Despite State-of-the-Art Water Treatment," Annals of Internal Medicine, 124(5):459-468.
13. Shunney, Jane, R.N. (Sept. 25, 1996), Clark County Department of Health, Las Vegas, Nevada.
14. Walker-Smith, J.A., J. Richard Hamilton, and W. Allan Walker, eds. (1996) Practical Pediatric Gastroenterology, 2nd ed., Hamilton, Ontario: B.C. Decker, Inc.